Analysen von Matthew Weston
| 12:36 | Novo Nordisk Neutral | UBS AG | |
| 14.11.25 | Merck Buy | UBS AG | |
| 13.11.25 | Merck Buy | UBS AG | |
| 11.11.25 | Novo Nordisk Neutral | UBS AG | |
| 10.11.25 | Novo Nordisk Neutral | UBS AG | |
| 10.11.25 | Roche Buy | UBS AG | |
| 07.11.25 | AstraZeneca Buy | UBS AG | |
| 06.11.25 | AstraZeneca Buy | UBS AG | |
|
Werbung
|
|||
| 06.11.25 | Novo Nordisk Neutral | UBS AG | |
| 05.11.25 | Novo Nordisk Neutral | UBS AG | |
| 04.11.25 | Novartis Neutral | UBS AG | |
| 31.10.25 | AstraZeneca Buy | UBS AG | |
| 30.10.25 | GSK Neutral | UBS AG | |
| 29.10.25 | Merck Buy | UBS AG | |
| 29.10.25 | Novartis Neutral | UBS AG | |
| 29.10.25 | GSK Neutral | UBS AG | |
| 27.10.25 | Sanofi Buy | UBS AG | |
| 24.10.25 | Sanofi Buy | UBS AG | |
| 24.10.25 | GSK Neutral | UBS AG | |
| 23.10.25 | Roche Buy | UBS AG | |
| 22.10.25 | GSK Neutral | UBS AG | |
| 22.10.25 | Novo Nordisk Neutral | UBS AG | |
| 20.10.25 | Merck Buy | UBS AG | |
| 17.10.25 | Merck Buy | UBS AG | |
| 13.10.25 | AstraZeneca Buy | UBS AG | |
| 13.10.25 | Roche Buy | UBS AG | |
| 13.10.25 | Novo Nordisk Neutral | UBS AG | |
| 13.10.25 | Novartis Neutral | UBS AG | |
| 10.10.25 | Novartis Neutral | UBS AG | |
| 10.10.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
| 10.10.25 | Sartorius vz. Neutral | UBS AG | |
| 06.10.25 | Novo Nordisk Neutral | UBS AG | |
| 03.10.25 | Novo Nordisk Neutral | UBS AG | |
| 03.10.25 | Sanofi Buy | UBS AG | |
| 24.09.25 | Novartis Neutral | UBS AG | |
| 23.09.25 | Roche Buy | UBS AG | |
| 23.09.25 | Novartis Neutral | UBS AG | |
| 23.09.25 | Novo Nordisk Neutral | UBS AG | |
| 18.09.25 | Novo Nordisk Neutral | UBS AG | |
| 16.09.25 | Novo Nordisk Neutral | UBS AG | |
| 15.09.25 | Novo Nordisk Neutral | UBS AG | |
| 12.09.25 | Novartis Neutral | UBS AG | |
| 10.09.25 | Novo Nordisk Neutral | UBS AG | |
| 09.09.25 | Sanofi Buy | UBS AG | |
| 08.09.25 | Novo Nordisk Neutral | UBS AG | |
| 05.09.25 | Novartis Neutral | UBS AG | |
| 05.09.25 | Novo Nordisk Neutral | UBS AG | |
| 04.09.25 | Sanofi Buy | UBS AG | |
| 04.09.25 | Roche Buy | UBS AG | |
| 01.09.25 | Novo Nordisk Neutral | UBS AG | |